(Applicant?s Description) The H. Lee Moffitt Cancer Center requests renewal of its National Cancer Institute (NCI) Center Core Support Grant (CCSG) for years 4-8 and designation as a Comprehensive Cancer Center. The Center has continued its remarkable growth, nearly doubling both its NCI and total peer reviewed funding during the first two years of the CCSG. The Center has added nearly 50,000 sq ft of new research space and will add another 200,000 sq ft of new research space in 2003. All of the commitments to the growth of the Center and its scientific staff will allow it to achieve its sole mission of """"""""contributing to the prevention and cure of cancer."""""""" As one of only a handful of freestanding centers located on a university campus, the Moffitt Cancer Center enjoys the benefits of being freestanding within the intellectual arena of a university based matrix center. In addition, the Center benefits from extraordinary support from the State of Florida, the University of South Florida and its own Board of Directors. The Center, which brings together all clinical and research approaches to cancer at the University of South Florida under one management structure, seeks support for four scientific programs, 11 shared resources, seven staff investigators, developmental funds and administration. In 1997, the Cancer Center asked the site reviewers to recognize the Center?s potential to become a major NCI designated cancer center and contributor to the national cancer research program. The Moffitt Cancer Center has remained true to that commitment and seeks to expand upon it.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA076292-06S1
Application #
6741592
Study Section
Subcommittee G - Education (NCI)
Program Officer
Rosenfeld, Bobby
Project Start
1998-02-19
Project End
2006-01-31
Budget Start
2003-04-22
Budget End
2004-01-31
Support Year
6
Fiscal Year
2003
Total Cost
$106,250
Indirect Cost
Name
University of South Florida
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
069687242
City
Tampa
State
FL
Country
United States
Zip Code
33612
Simmons, Vani N; Sutton, Steven K; Meltzer, Lauren R et al. (2018) Long-term outcomes from a self-help smoking cessation randomized controlled trial. Psychol Addict Behav 32:710-714
Dai, Juncheng; Li, Zhihua; Amos, Christopher I et al. (2018) Systematic analyses of regulatory variants in DNase I hypersensitive sites identified two novel lung cancer susceptibility loci. Carcinogenesis :
Cherezov, Dmitry; Hawkins, Samuel H; Goldgof, Dmitry B et al. (2018) Delta radiomic features improve prediction for lung cancer incidence: A nested case-control analysis of the National Lung Screening Trial. Cancer Med 7:6340-6356
Neumeyer, Sonja; Banbury, Barbara L; Arndt, Volker et al. (2018) Mendelian randomisation study of age at menarche and age at menopause and the risk of colorectal cancer. Br J Cancer 118:1639-1647
Wheldon, Christopher W; Schabath, Matthew B; Hudson, Janella et al. (2018) Culturally Competent Care for Sexual and Gender Minority Patients at National Cancer Institute-Designated Comprehensive Cancer Centers. LGBT Health 5:203-211
Lin, Hui-Yi; Huang, Po-Yu; Chen, Dung-Tsa et al. (2018) AA9int: SNP interaction pattern search using non-hierarchical additive model set. Bioinformatics 34:4141-4150
Palmer, Amanda M; Brandon, Thomas H (2018) How do electronic cigarettes affect cravings to smoke or vape? Parsing the influences of nicotine and expectancies using the balanced-placebo design. J Consult Clin Psychol 86:486-491
Hellmann, Matthew D; Callahan, Margaret K; Awad, Mark M et al. (2018) Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung Cancer. Cancer Cell 33:853-861.e4
Trabert, Britton; Poole, Elizabeth M; White, Emily et al. (2018) Analgesic Use and Ovarian Cancer Risk: An Analysis in the Ovarian Cancer Cohort Consortium. J Natl Cancer Inst :
Liu, Ying; Kim, Jongphil; Balagurunathan, Yoganand et al. (2018) Prediction of pathological nodal involvement by CT-based Radiomic features of the primary tumor in patients with clinically node-negative peripheral lung adenocarcinomas. Med Phys 45:2518-2526

Showing the most recent 10 out of 1254 publications